Search
Flesinoxan
go.drugbank.com/drugs/DB19853ExperimentalThe usage of the INN stem '-oxan(e)' in the name indicates that Flesinoxan is a benzodioxane derivative. Flesinoxan has a monoisotopic molecular weight of 415.19 Da.
Ornoprostil
go.drugbank.com/drugs/DB20791ExperimentalOrnoprostil is a small molecule drug. The usage of the INN stem '-prostil' in the name indicates that Ornoprostil is a anti-ulcer prostaglandin. Ornoprostil has a monoisotopic molecular weight of 410.27 Da.
Categories: Prostaglandins E, Prostaglandins E, SyntheticSobuzoxane
go.drugbank.com/drugs/DB21119ExperimentalThe usage of the INN stem '-oxan(e)' in the name indicates that Sobuzoxane is a benzodioxane derivative. Sobuzoxane has a monoisotopic molecular weight of 514.23 Da.
Fluparoxan
go.drugbank.com/drugs/DB21336ExperimentalThe usage of the INN stem '-oxan(e)' in the name indicates that Fluparoxan is a benzodioxane derivative. Fluparoxan has a monoisotopic molecular weight of 195.07 Da.
Ubiquinol
go.drugbank.com/drugs/DB11340ApprovedInvestigationalIt plays an essential role in maintaining cellular defense against oxidative damage and also sustains the effects of vitamin E by regenerating the vitamin from the tocopheroxyl radical, but ubiquinol is
Tocofersolan
go.drugbank.com/drugs/DB11635ApprovedTocofersolan is an oral treatment of vitamin E deficiency due to digestive malabsorption in pediatric patients with congenital chronic cholestasis or hereditary chronic cholestasis. … D-Alpha-tocopheryl polyethylene glycol 1000 succinate (Tocofersolan, Vedrop), has been developed in Europe as an orally bioavailable source of vitamin E in children suffering from cholestasis [L2371].
Categories: Vitamin ESynonyms: VITAMIN E POLYETHYLENE GLYCOL SUCCINATE, VITAMIN E POLYETHYLENE GLYCOL 1000 SUCCINATEBasimglurant
go.drugbank.com/drugs/DB11833InvestigationalBasimglurant has been used in trials studying the diagnostic and treatment of Depression, Fragile X Syndrome, and Major Depressive Disorder.
PF-04418948
go.drugbank.com/drugs/DB12024InvestigationalPf 04418948 is under investigation in clinical trial NCT01002963 (A Study To Investigate The Safety And Toleration Of A Single Dose Of PF-04418948 In Healthy Volunteers).
Categories: Receptors, Prostaglandin E, EP2 SubtypePolatuzumab vedotin
go.drugbank.com/drugs/DB12240ApprovedInvestigationalPolatuzumab vedotin is a CD79b-directed antibody-drug conjugate that delivers monomethyl auristatin E (MMAE), an anti-mitotic agent, to cancer cells.
Eltanolone
go.drugbank.com/drugs/DB12308ExperimentalEltanolone is under investigation in clinical trial NCT02603926 (Treatment of Fragile-X Associated Tremor/Ataxia Syndrome (FXTAS) With Allopregnanolone).